Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1967 2
1970 1
1971 1
1973 1
1974 3
1975 2
1976 2
1977 2
1978 1
1979 4
1980 11
1981 5
1982 6
1983 2
1984 5
1985 7
1986 5
1987 5
1988 7
1989 4
1990 9
1991 7
1992 8
1993 8
1994 6
1995 9
1996 5
1997 6
1998 9
1999 9
2000 7
2001 7
2002 12
2003 8
2004 13
2005 17
2006 19
2007 24
2008 24
2009 32
2010 21
2011 16
2012 27
2013 32
2014 38
2015 52
2016 46
2017 46
2018 60
2019 63
2020 59
2021 53
2022 56
2023 60
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

824 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.
Authors/Task Force Members:; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. Authors/Task Force Members:, et al. Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333. Eur J Heart Fail. 2022. PMID: 35083827 Free article.
Lund (Sweden), Donna Mancini (United States of America), Josep Masip (Spain), Davor Milicic (Croatia), Christian Mueller (Switzerland), Holger Nef (Germany), Jens-Cosedis Nielsen (Denmark), Lis Neubeck (United Kingdom), Michel Noutsias (Germany), Steffen E. ...Richter (Gre …
Lund (Sweden), Donna Mancini (United States of America), Josep Masip (Spain), Davor Milicic (Croatia), Christian Mueller (Switzerland), Holg …
Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure.
Schjørring OL, Klitgaard TL, Perner A, Wetterslev J, Lange T, Siegemund M, Bäcklund M, Keus F, Laake JH, Morgan M, Thormar KM, Rosborg SA, Bisgaard J, Erntgaard AES, Lynnerup AH, Pedersen RL, Crescioli E, Gielstrup TC, Behzadi MT, Poulsen LM, Estrup S, Laigaard JP, Andersen C, Mortensen CB, Brand BA, White J, Jarnvig IL, Møller MH, Quist L, Bestle MH, Schønemann-Lund M, Kamper MK, Hindborg M, Hollinger A, Gebhard CE, Zellweger N, Meyhoff CS, Hjort M, Bech LK, Grøfte T, Bundgaard H, Østergaard LHM, Thyø MA, Hildebrandt T, Uslu B, Sølling CG, Møller-Nielsen N, Brøchner AC, Borup M, Okkonen M, Dieperink W, Pedersen UG, Andreasen AS, Buus L, Aslam TN, Winding RR, Schefold JC, Thorup SB, Iversen SA, Engstrøm J, Kjær MN, Rasmussen BS; HOT-ICU Investigators. Schjørring OL, et al. N Engl J Med. 2021 Apr 8;384(14):1301-1311. doi: 10.1056/NEJMoa2032510. Epub 2021 Jan 20. N Engl J Med. 2021. PMID: 33471452 Clinical Trial.
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.
Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Dürig J, Forstpointner R, Herold M, Hertzberg M, Klanova M, Radford J, Seymour JF, Tobinai K, Trotman J, Burciu A, Fingerle-Rowson G, Wolbers M, Nielsen T, Marcus RE. Hiddemann W, et al. J Clin Oncol. 2018 Aug 10;36(23):2395-2404. doi: 10.1200/JCO.2017.76.8960. Epub 2018 Jun 1. J Clin Oncol. 2018. PMID: 29856692 Clinical Trial.
Responding patients received G or R for 2 years or until disease progression. Results Baseline Follicular Lymphoma International Prognostic Index risk, bulky disease, and comorbidities differed by chemotherapy. ...Fatal events were more frequent in patients treated with be …
Responding patients received G or R for 2 years or until disease progression. Results Baseline Follicular Lymphoma International Prog …
Macrocyclic G-quadruplex ligands.
Nielsen MC, Ulven T. Nielsen MC, et al. Curr Med Chem. 2010;17(29):3438-48. doi: 10.2174/092986710793176320. Curr Med Chem. 2010. PMID: 20712562 Review.
G-quadruplex stabilizing compounds have recently received increased interest due to their potential application as anticancer therapeutics. ...These two structural classes of G-quadruplex ligands are reviewed here with special attention to selectivity and structure- …
G-quadruplex stabilizing compounds have recently received increased interest due to their potential application as anticancer therape …
Recent achievements in developing selective G(q) inhibitors.
Zhang H, Nielsen AL, Strømgaard K. Zhang H, et al. Med Res Rev. 2020 Jan;40(1):135-157. doi: 10.1002/med.21598. Epub 2019 Jun 19. Med Res Rev. 2020. PMID: 31218731 Review.
G proteins are key mediators of G protein-coupled receptor (GPCR) signaling, facilitating a plethora of important physiological processes. The role of G proteins is much less understood than other aspects of GPCR function, which is largely due to the shortage …
G proteins are key mediators of G protein-coupled receptor (GPCR) signaling, facilitating a plethora of important physiologica …
PMS2-associated Lynch syndrome: Past, present and future.
Andini KD, Nielsen M, Suerink M, Helderman NC, Koornstra JJ, Ahadova A, Kloor M, Mourits MJE, Kok K, Sijmons RH, Bajwa-Ten Broeke SW. Andini KD, et al. Front Oncol. 2023 Feb 21;13:1127329. doi: 10.3389/fonc.2023.1127329. eCollection 2023. Front Oncol. 2023. PMID: 36895471 Free PMC article. Review.
These findings could have important consequences for surveillance, chemoprevention and therapeutic strategies (e.g. vaccines). In this review we discuss the current knowledge, current (clinical) challenges and knowledge gaps that should be targeted by future studies....
These findings could have important consequences for surveillance, chemoprevention and therapeutic strategies (e.g. vaccines). In thi …
The G protein coupled receptor CCR5 in cancer.
Upadhyaya C, Jiao X, Ashton A, Patel K, Kossenkov AV, Pestell RG. Upadhyaya C, et al. Adv Cancer Res. 2020;145:29-47. doi: 10.1016/bs.acr.2019.11.001. Epub 2020 Jan 10. Adv Cancer Res. 2020. PMID: 32089164 Free PMC article. Review.
The G coupled protein receptor CC chemokine receptor type 5 (CCR5) has the unusual characteristic in humans of being a developmentally non-essential gene that participates in several pathological processes including infection with HIV (Dean et al., 1996; Gupta et al., 2019 …
The G coupled protein receptor CC chemokine receptor type 5 (CCR5) has the unusual characteristic in humans of being a developmentall …
The post-transcriptional operon.
Tenenbaum SA, Christiansen J, Nielsen H. Tenenbaum SA, et al. Methods Mol Biol. 2011;703:237-45. doi: 10.1007/978-1-59745-248-9_16. Methods Mol Biol. 2011. PMID: 21125494
The post-transcriptional operon model (PTO) is used to describe data from an assortment of methods (e.g. RIP-Chip, CLIP-Chip, miRNA profiling, ribosome profiling) that globally address the functionality of mRNA. ...
The post-transcriptional operon model (PTO) is used to describe data from an assortment of methods (e.g. RIP-Chip, CLIP-Chip, miRNA p …
Thrombogenesis.
Nielsen JD. Nielsen JD. Ann Chir Gynaecol. 1995;84(4):327-34. Ann Chir Gynaecol. 1995. PMID: 8687075 Review.
Thrombosis occurs when there is a breakdown in the balance between thrombogenic factors and protective mechanisms. The thrombogenic factors may be exogenous (e.g. trauma, surgery), endogenous (e.g. cancer, vascular diseases) or both (e.g. atherosclerosis, com …
Thrombosis occurs when there is a breakdown in the balance between thrombogenic factors and protective mechanisms. The thrombogenic factors …
824 results